Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms

被引：0
|
作者：
Lim, Ken-Hong [1 ,2 ]
Matsuura, Shinobu [3 ]
Xu, Bing [4 ,5 ,6 ]
机构：
[1] MacKay Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taipei, Taiwan
[2] MacKay Med Coll, Dept Med, New Taipei, Taiwan
[3] Boston Univ, Sch Med, Dept Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA
[4] Xiamen Univ, Affiliated Hosp 1, Dept Hematol, Xiamen, Peoples R China
[5] Xiamen Univ, Inst Hematol, Sch Med, Xiamen, Peoples R China
[6] Key Lab Xiamen Diag & Treatment Hematol Malignanc, Xiamen, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词：
myeloproliferative neoplasms; chronic myeloid leukemia; CALR; MPL; tyrosine kinase inhibitor; THROMBOPOIETIN RECEPTOR; CALRETICULIN; ACTIVATION;
D O I：
10.3389/fonc.2021.762928
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Novel therapeutic options in the treatment of BCR/ABL-negative myeloproliferative neoplasms
    Doehner, K.
    Stegelmann, F.
    Schlenk, R. F.
    Griesshammer, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (42) : 2171 - 2178
  • [22] Therapiestrategien bei myeloproliferativen NeoplasienTreatment strategies for myeloproliferative neoplasms
    Florian Heidel
    Die Onkologie, 2022, 28 (8) : 721 - 730
  • [23] Role of Additional Novel Therapies in Myeloproliferative Neoplasms
    Fiskus, Warren
    Ganguly, Siddhartha
    Kambhampati, Suman
    Bhalla, Kapil N.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (05) : 959 - +
  • [24] Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms
    Brandi N. Reeves
    Joan D. Beckman
    Current Hematologic Malignancy Reports, 2021, 16 : 304 - 313
  • [25] Novel Pathophysiological Mechanisms of Thrombosis in Myeloproliferative Neoplasms
    Reeves, Brandi N.
    Beckman, Joan D.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2021, 16 (03) : 304 - 313
  • [26] Editorial: Biological and clinical implications of the mutational landscape in myeloproliferative neoplasms
    Loscocco, Giuseppe Gaetano
    Mora, Barbara
    Gangat, Naseema
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Myeloproliferative neoplasms: A decade of discoveries and treatment advances
    Tefferi, Ayalew
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (01) : 50 - 58
  • [28] Targeting calreticulin neoantigen for the treatment of myeloproliferative neoplasms
    Araki, Marito
    Komatsu, Norio
    CANCER SCIENCE, 2021, 112 : 507 - 507
  • [29] Janus kinase inhibitors for the treatment of myeloproliferative neoplasms
    Rosenthal, Allison
    Mesa, Ruben A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (09) : 1265 - 1276
  • [30] Myeloproliferative Neoplasms: Emerging Treatment Options for Myelofibrosis
    Gerds, Aaron T.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (12): : 1788 - 1791
12345